Page 166 - scheppingen

six
164
References
1. Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011 Jan;7(1):31-40.
2. Aronica E, Ravizza T, Zurolo E, Vezzani A. Astrocyte immune responses in epilepsy. Glia. 2012 Aug;60(8):1258-68.
3. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007 Mar;28(3):138-45.
4. Colombo E, Farina C. Astrocytes: Key Regulators of Neuroinflammation. Trends Immunol. 2016 Sep;37(9):608-20.
5. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010 Jan;119(1):7-35.
6. Sierra A, Martin-Suarez S, Valcarcel-Martin R, et al. Neuronal hyperactivity accelerates depletion of neural stem cells and impairs hippocampal neurogenesis. Cell Stem Cell. 2015 May 07;16(5):488-503.
7. Cui M, Huang Y, Tian C, Zhao Y, Zheng J. FOXO3a inhibits TNF-α- and IL-1β-induced astrocyte proliferation:Implication for reactive astrogliosis. Glia. 2011;59:641-54.
8. Xanthos DN, Sandkuhler J. Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci. 2014 Jan;15(1):43-53.
9. Srinivasan D, Yen JH, Joseph DJ, Friedman W. Cell type-specific interleukin-1beta signaling in the CNS. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2004 Jul 21;24(29):6482-8.
10. Moynagh PN. The interleukin-1 signalling pathway in astrocytes: a key contributor to inflammation in the brain. J Anat. 2005 Sep;207(3):265-9.
11. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A. Innate and adaptive immunity during epi- leptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis. 2008 Jan;29(1):142-60.
12. Sparacio SM, Zhang Y, Vilcek J, Benveniste EN. Cytokine regulation of interleukin-6 gene expres- sion in astrocytes involves activation of an NF-kappa B-like nuclear protein. J Neuroimmunol. 1992 Aug;39(3):231-42.
13. Aronica E, Bauer S, Bozzi Y, et al. Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia. 2017 Jul;58 Suppl 3:27-38.
14. Li L, Chen XP, Li YJ. MicroRNA-146a and human disease. Scand J Immunol. 2010 Apr;71(4):227-31.
15. Li MM, Li XM, Zheng XP, Yu JT, Tan L. MicroRNAs dysregulation in epilepsy. Brain Res. 2014 Oct
10;1584:94-104.
16. Gorter JA, Iyer A, White I, et al. Hippocampal subregion-specific microRNA expression during
epileptogenesis in experimental temporal lobe epilepsy. Neurobiol Dis. 2014 Feb;62:508-20.
17. van Scheppingen J, Iyer AM, Prabowo AS, et al. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and
SEGA-derived cell cultures. Glia. 2016;64:1066-82.
18. Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-associ-
ated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci. 2010
Mar;31(6):1100-7.
19. Iyer A, Zurolo E, Prabowo A, et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflam-
matory response. PloS one. 2012;7(9):e44789.
20. Iori V, Iyer AM, Ravizza T, et al. Blockade of the IL-1R1/TLR4 pathway mediates disease-modification
therapeutic effects in a model of acquired epilepsy. Neurobiol Dis. 2017 Mar;99:12-23.
21. van Scheppingen J, Broekaart DW, Scholl T, et al. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development. Journal of neuroinflammation. 2016 Aug
26;13(1):202.
22. Mills JD, Iyer AM, van Scheppingen J, et al. Coding and small non-coding transcriptional landscape
of tuberous sclerosis complex cortical tubers: implications for pathophysiology and treatment.
Scientific reports. 2017 Aug 14;7(1):8089.
23. Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data.
Bioinformatics. 2014 Aug 01;30(15):2114-20.
24. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using